 Mutation
"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 16 | 20 | | 1997 | 7 | 20 | 27 | | 1998 | 15 | 19 | 34 | | 1999 | 3 | 24 | 27 | | 2000 | 10 | 32 | 42 | | 2001 | 7 | 44 | 51 | | 2002 | 14 | 41 | 55 | | 2003 | 12 | 60 | 72 | | 2004 | 11 | 54 | 65 | | 2005 | 8 | 62 | 70 | | 2006 | 13 | 68 | 81 | | 2007 | 31 | 54 | 85 | | 2008 | 31 | 64 | 95 | | 2009 | 19 | 66 | 85 | | 2010 | 21 | 72 | 93 | | 2011 | 25 | 68 | 93 | | 2012 | 36 | 75 | 111 | | 2013 | 36 | 89 | 125 | | 2014 | 41 | 100 | 141 | | 2015 | 52 | 85 | 137 | | 2016 | 45 | 120 | 165 | | 2017 | 34 | 118 | 152 | | 2018 | 50 | 110 | 160 | | 2019 | 45 | 120 | 165 | | 2020 | 31 | 91 | 122 | | 2021 | 28 | 118 | 146 | | 2022 | 5 | 128 | 133 | | 2023 | 1 | 94 | 95 | | 2024 | 25 | 62 | 87 | | 2025 | 27 | 73 | 100 | | 2026 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Waliany S, Cooper AJ, Liu SV, Gautschi O, Rotow JK, Smith KER, Weber UM, Lee DH, Loong HHF, Patel JD, Pennell NA, Nagasaka M, Patel SA, Tan DSW, Solomon BJ, Kim TM, Pall G, Riess JW, Sun L, Früh M, Uy NF, Gadgeel S, Feng J, Do A, Falcon C, Leighl NB, Baik CS, Lai GGY, Ou SI, Cheung KSY, Patil T, Mansfield AS, Weiler D, Yeap BY, Wirth LJ, Gainor JF, Drilon A, Lin JJ. Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium. Clin Cancer Res. 2026 Mar 16; 32(6):1157-1168.
-
Nassour J, Karlseder J. Telomere Crisis Shapes Cancer Evolution. Cold Spring Harb Perspect Biol. 2026 Mar 02; 18(3).
-
Martin-Martin A, Chipón C, Guzman-Kunstmann C, Guzman-Kunstmann S, Buelvas N, Henríquez C, Vidal F, Villarroel-Espindola F, Hinz TK, Heasley LE, López-Muñoz RA. The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation. Biol Res. 2026 Feb 19; 59(1).
-
Shao C, Indeglia A, Foster M, Casey K, Leung J, Modarai SR, Leu JI, Duong B, Mes-Masson AM, Sims-Mourtada J, Auslander N, Drapkin R, Bitler BG, Zhang N, Murphy ME. Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. Genes Dev. 2026 Feb 02; 40(3-4):199-214.
-
Lopriore P, Ünlütürk Z, Klopstock T, Karaa A, Rouzier C, Domínguez-González C, Lamperti C, Mancuso M, Cecchi G, Montano V, Siciliano G, Nicoletta V, Maioli M, Primiano G, Servidei S, La Morgia C, Carelli V, Valentino ML, Caporali L, Arena IG, Musumeci O, Lopergolo D, Malandrini A, Gallus GN, Filosto M, Bello L, Pegoraro E, Comi GP, Magri F, Ronchi D, Di Fonzo A, Percetti M, Azzimonti M, Büchner B, Prokisch H, Bermejo-Guerrero L, Procaccio V, Gaignard P, Echaniz-Laguna A, Schiff M, Rötig A, Toutain A, Paquis-Flucklinger V, Morel G, Robin S, Nadaj-Pakleza A, Chanson JB, Chaussenot A, Ait-El-Mkadem Saadi S, Trimouille A, Tranchant C, Salort-Campana E, Bieth E, Sacconi S, Duval F, Restrepo Vera JL, Molnar MJ, Vissing J, Haas R, Larson A, Enns GM, Parikh S, Goldstein A, Hirano M. Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study. Neurology. 2026 Feb 10; 106(3):e214401.
-
Fuchs HA, Peng Y, Ayyapan S, Rosas R, Zhang H, Panchenko AR, Musselman CA. G34R cancer mutation alters the conformational ensemble and dynamics of the histone H3.3 tails. Nucleic Acids Res. 2026 Jan 14; 54(2).
-
Yasin I, Stengel A, Shao H, Kaur A, Mason EF, Patwardhan PP, Bailey NG, Ghosh S, Inamdar KV, Patel AA, Pandiri M, Zhang J, Sojitra P, Tariq H, Pan Z, Wiredja D, Wang P, Tjota MY, Segal JP, Chang H, Sallman DA, Arber DA, Tefferi A, Badar T, Perry AM, Haferlach C, Lager AM, Venkataraman G. Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
-
Agulnik M, Wilky BA, Thorpe SW, Zuckerman LM. Chondrosarcoma: Clinical behavior, molecular mechanisms, and emerging therapeutic strategies. Crit Rev Oncol Hematol. 2026 Feb; 218:105075.
-
Sessions DT, Boulton DP, Spoelstra NS, Caino MC, Yu M, Goodspeed A, Richer JK. Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 2025 Dec 05; 167(1).
-
Huey LM, Rosenzweig HL, Napier RJ. Resolving the field: a role for Nod2 in T cells. J Immunol. 2025 Dec 01; 214(12):3188-3198.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|